about
MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenibMale germ cell-specific RNA binding protein RBMY: a new oncogene explaining male predominance in liver cancerTGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.Reduced susceptibility of DNA methyltransferase 1 hypomorphic (Dnmt1N/+) mice to hepatic steatosis upon feeding liquid alcohol diet.mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues.Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog.Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alphaEssential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumorHepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure.Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.MicroRNA-122 regulates polyploidization in the murine liver.Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2.Lipid nanoparticles for hepatic delivery of small interfering RNA.Pathological polyploidy in liver disease.Cutaneous and sympathetic denervation in neonatal rats with a mutation in the delta subunit of the cytosolic chaperonin-containing t-complex peptide-1 gene.Ultrasonographic Technique for Imaging and Injecting the Superior Cluneal Nerve
P50
Q24655048-8345D420-CE45-492B-85F1-6AAAA7CA9DF0Q28477819-5E5CC0E9-E5DA-43AA-85BF-08735FE81302Q33754007-D44A35EC-C9F8-4BB5-B086-AFBDD45D0077Q34384312-BAC3D02B-A711-43F9-AFA5-A5A8995CAB17Q34939285-62CAEDFD-6D35-4B5E-9720-E1DBB252FC62Q34940543-158AC98F-107A-4696-8F70-CCE0BD1D0DACQ35968941-F30F0155-F8C9-4A63-837E-9FCC1D675E2BQ36129129-5F493D00-1A1C-4232-8A42-F36EC7D34A13Q37275063-20BA6129-B169-44B2-B567-40F39FAF6C1DQ37379190-C656B89A-B2A0-4E05-9887-D09D6D2D6005Q38726039-821D4B3B-2080-41BF-A8BF-A919DBCF38DEQ38890010-D67B4601-6022-4996-808A-64DC81140AC1Q39095795-120C6F53-B83C-48D3-B0E1-99E8F85F3177Q39339170-0E17DD1A-4989-41C1-97B7-006D2894E9A2Q42842053-7817171C-2247-4C22-8D01-B007B25C976BQ44933205-3C43D3EB-89AD-4ACE-B479-11AF3DEA1444Q88579474-F160B159-EE9A-479F-B19D-1D65745674CB
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Shu-hao Hsu
@ast
Shu-hao Hsu
@en
Shu-hao Hsu
@es
Shu-hao Hsu
@nl
type
label
Shu-hao Hsu
@ast
Shu-hao Hsu
@en
Shu-hao Hsu
@es
Shu-hao Hsu
@nl
prefLabel
Shu-hao Hsu
@ast
Shu-hao Hsu
@en
Shu-hao Hsu
@es
Shu-hao Hsu
@nl
P106
P1153
35765573600
P31
P496
0000-0002-9444-4192